Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survey and Reduction of Mortality in Uremic Patients During Peridialysis Period Via Intervention of Risk Factors

NCT04088526 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.

NCT NCT04088526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04088526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survey and Reduction of Mortality in Uremic Patients During Peridialysis Period Via Intervention of Risk Factors
Lead sponsor
Shanghai Changzheng Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2016
Completion date
December 31, 2021
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease on dialysis